Literature DB >> 21173701

Survey of complementary and alternative medicine use in glaucoma patients.

Michael J Wan1, Shannon Daniel, Faazil Kassam, Gaganpal Mutti, Ziad Butty, Oscar Kasner, Graham E Trope, Yvonne M Buys.   

Abstract

PURPOSE: To determine the prevalence, types, and associated factors of complementary and alternative medicine (CAM) use in glaucoma patients. PATIENTS AND METHODS: Prospective, multicenter, cross-sectional survey. A total of 1516 consecutive patients attending 2 tertiary glaucoma clinics were surveyed on CAM use. Information gathered on standardized data collection sheets included demographic variables, ophthalmic history, glaucoma treatment history, and details of CAM use.
RESULTS: The response rate was 92.5%. A total of 166 patients (10.9%) reported current use of CAM therapy specifically for glaucoma whereas 41 patients (2.7%) reported past use of CAM. Of the patients who reported CAM use, 62.5% had not disclosed the use of CAM to their ophthalmologist and 40.5% believed that the treatments were helping their glaucoma. The most commonly used types of CAM were herbal medications (34.5%), dietary modifications (22.7%), and vitamin/mineral supplements (18.8%). Of the 207 patients who reported current or past CAM use for their glaucoma, 3 (1.4%) indicated that they used conventional glaucoma treatments < prescribed because of their CAM use.
CONCLUSIONS: Approximately 1 in 9 glaucoma patients use CAM for their disease. Many of these patients do not disclose the use of CAM to their ophthalmologist, but the vast majority report that they still take conventional glaucoma medications as prescribed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21173701     DOI: 10.1097/IJG.0b013e3182027c0c

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  11 in total

Review 1.  Modifiable factors in the management of glaucoma: a systematic review of current evidence.

Authors:  Idan Hecht; Asaf Achiron; Vitaly Man; Zvia Burgansky-Eliash
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-14       Impact factor: 3.117

Review 2.  Dietary factors and the risk of glaucoma: a review.

Authors:  Igor I Bussel; Ahmad A Aref
Journal:  Ther Adv Chronic Dis       Date:  2014-07       Impact factor: 5.091

3.  Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States.

Authors:  S Y Wang; K Singh; S C Lin
Journal:  Eye (Lond)       Date:  2013-02-22       Impact factor: 3.775

4.  Acupuncture for glaucoma.

Authors:  Simon K Law; Lin Wang; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2020-02-07

5.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

Review 6.  The Role of Diet in Glaucoma: A Review of the Current Evidence.

Authors:  Adi M Al Owaifeer; Abdulaziz A Al Taisan
Journal:  Ophthalmol Ther       Date:  2018-02-08

7.  Use of complementary and alternative therapies by patients with eye diseases: a hospital-based cross-sectional study from Palestine.

Authors:  Dania Jaber; Rafat Abu Ghannam; Waleed Rashed; Mohammad Shehadeh; Sa'ed H Zyoud
Journal:  BMC Complement Med Ther       Date:  2021-01-04

8.  The Proportion of Complementary and Alternative Medicine Utilization Among Saudi Population for Eye Care: Cross-Sectional Study.

Authors:  Salma AlSalman; Munira A AlHussaini; Rajiv B Khandekar; Deepak P Edward
Journal:  Cureus       Date:  2021-02-03

Review 9.  Complementary and Alternate Management of Glaucoma: The Verdict so Far.

Authors:  Shibal Bhartiya; Parul Ichhpujani
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12

Review 10.  Herbal Medicines in Glaucoma Treatment.

Authors:  Maryam Ige; Ji Liu
Journal:  Yale J Biol Med       Date:  2020-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.